Cargando…

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), the most prominent cause of chronic liver disease worldwide, is a rapidly growing epidemic. It consists of a wide range of liver diseases, from steatosis to nonalcoholic steatohepatitis, and predisposes patients to liver fibrosis, cirrhosis, and even hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggeletopoulou, Ioanna, Kalafateli, Maria, Tsounis, Efthymios P., Triantos, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454848/ https://www.ncbi.nlm.nih.gov/pubmed/37629043 http://dx.doi.org/10.3390/ijms241612864

Ejemplares similares

Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2022)

Creeping Fat in Crohn’s Disease—Surgical, Histological, and Radiological Approaches
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Epidemiology of hepatitis C in Greece
por: Triantos, Christos, et al.
Publicado: (2016)

Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential
por: Eleftheriotis, Gerasimos, et al.
Publicado: (2023)

Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2022)

Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure
por: Tsounis, Efthymios P, et al.
Publicado: (2021)

miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Vitamin D deficiency in patients with liver cirrhosis
por: Konstantakis, Christos, et al.
Publicado: (2016)

Nucleic acid vaccines: A taboo broken and prospect for a hepatitis B virus cure
por: Tsounis, Efthymios P, et al.
Publicado: (2021)

Νon-invasive screening for esophageal varices in patients with liver cirrhosis
por: Karatzas, Andreas, et al.
Publicado: (2018)

The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease
por: Tourkochristou, Evanthia, et al.
Publicado: (2023)

Intestinal barrier dysfunction as a key driver of severe COVID-19
por: Tsounis, Efthymios P, et al.
Publicado: (2023)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Role of band ligation for secondary prophylaxis of variceal bleeding
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2018)

The role of vitamin D receptor polymorphisms in the course of chronic hepatitis C infection
por: Tsounis, Efthymios P., et al.
Publicado: (2022)

Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis
por: Triantos, Christos, et al.
Publicado: (2018)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023)

Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease
por: Zaiou, Mohamed
Publicado: (2022)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Alexithymic characteristics and interoceptive abilities are associated with disease severity and levels of C-reactive protein and cytokines in patients with inflammatory bowel disease
por: Vinni, Eleni, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Natural history of grade 1 ascites in patients with liver cirrhosis
por: Theodorakopoulos, Theodoros, et al.
Publicado: (2021)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
por: Liu, Lu, et al.
Publicado: (2022)

Innate immunity and nonalcoholic fatty liver disease
por: Kountouras, Jannis, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease
por: Zaiou, Mohamed
Publicado: (2023)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study
por: Li, Jie, et al.
Publicado: (2023)

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease
por: Shen, Nan, et al.
Publicado: (2023)

Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
por: Young, Steven, et al.
Publicado: (2020)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
por: Iino, Chikara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbtcas61ah8fs198m0112avgou